Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2026 Earnings Call Transcript February 12, 2026 Aethlon Medical, Inc. misses on ...

International expansion -- Initial clinical use of ReCell Go in select European markets established post-CE Mark approval, ...

At this time, I would like to welcome everyone to the Inspire Medical Systems, Inc. fourth quarter and full year 2025 conference call. Ezgi Yagci: Thank you, Delam, and thank you all for participating ...

Chief Executive Officer — Eric Schlorff Chief Commercial Officer — Tim Varacek Chief Medical Officer — Kevin Chung Controller — Brad Town Investor Relations — Jackie Cossmon Chief Medical Officer ...

Good morning, and thank you for standing by. Currently, all participants are in a listen-only mode. After management's discussion, there will be a question-and-answer session. Please be advised that ...

The permanence of artificial intelligence in healthcare is increasingly promising—and one of the most transformative use cases today is AI-powered medical transcription. AI medical scribes can reduce ...

CEO Treace stated, "we are not growing our line the way we anticipated for the year," while also noting case volume growth in Q3 2025 was still below original expectations and driven by lower-ASP ...

Scott Galovan stated, "We currently estimate the P&L impact of incremental tariff-related manufacturing costs, primarily for products originating from Mexico and China, to be approximately $18 million ...

AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2025 Earnings Call Transcript February 12, 2026 AVITA Medical, Inc. beats earnings expectations. Reported EPS is $-0.04171, expectations were $-0.4835. Operator: ...

At this time, I would like to welcome everyone to the Inspire Medical Systems Fourth Quarter and Full Year 2025 Conference Call. [Operator Instructions] I'll now hand the call over to your first ...